Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Aehr Test Systems (AEHR) vs Banco Bilbao Vizcaya Argentaria SA (BBVA) Price & Performance

Aehr Test SystemsTrade
Banco Bilbao Vizcaya Argentaria SATrade

Price performance (Past 24H)

Key statistics

Aehr Test Systems vs Banco Bilbao Vizcaya Argentaria SA — how do they compare? Aehr Test Systems trades at $118.72 (market cap $3.46B), while Banco Bilbao Vizcaya Argentaria SA trades at $28.61 (market cap $157.51B). The key difference: Banco Bilbao Vizcaya Argentaria SA is far larger — about 45.5× Aehr Test Systems's market cap, and Banco Bilbao Vizcaya Argentaria SA pays a 3.8% dividend while Aehr Test Systems pays none. Which is the better fit depends on your goals.

AEHRBBVA
Market Cap
$3.46B$157.51B
Sector
TechnologyFinancials
52-Week High
$117.18$28.50
52-Week Low
$17.38$17.96
Enterprise Value
$3.36B
Dividend Yield
3.8%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Aehr Test Systems

AEHR Test Systems trades at $103.07, up 3.34% with strong technical momentum and bullish moving average signals. The company shows improving earnings trends with three consecutive quarterly beats, though profitability remains negative with a -14.25% net margin. Recent news highlights significant silicon photonics orders and a strategic pivot toward AI infrastructure, driving investor optimism despite insider selling activity.

Outlook remains growth-focused with FY27 revenue guidance of 160-200% expansion, though high valuation (P/S 65.13) and customer concentration pose risks. Analyst consensus leans neutral with 33% buy ratings, while technical indicators suggest near-term support at $97 with resistance at $107. The stock's AI-driven backlog expansion supports bullish sentiment despite current negative cash flow.

Banco Bilbao Vizcaya Argentaria SA

BBVA trades at $28.35, up 0.75% today, with a bullish technical signal from moving averages and strong fundamental performance. The bank reported Q2 2026 net profit growth of 11.4% year-over-year, driven by Mexico operations, and announced a $2.3 billion buyback. Revenue reached $39.42 billion in 2025, with net income margin at 26.13% and ROE of 18.5%, though cash flow was negative in 2024.

Outlook is positive with raised profitability guidance (ROTE ~21%) and analyst consensus leaning buy (54%), but risks include a Spanish court trial for spying allegations and antitrust probes. The stock offers value with a P/E of 12.98, yet investors should monitor legal overhangs and macroeconomic volatility in core markets like Spain and Mexico.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Aehr Test Systems

Aehr Test Systems provides testing and burn-in solutions for the semiconductor industry. Its systems ensure the reliability of AI processors, data center chips, and electric vehicle components at the wafer and package levels.

Read more on AEHR

About Banco Bilbao Vizcaya Argentaria SA

Despite its Spanish origins, BBVA generates three quarters of its profits in emerging markets, especially Mexico that contributes nearly half of BBVA's net profit. BBVA is overwhelmingly a retail and commercial bank with corporate and investment banking forming a smaller part of the overall business.

Read more on BBVA